These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36098222)

  • 1. Molecular characteristics of multifocal esophageal squamous cell carcinomas to discriminate multicentric origin from intramural metastasis.
    Li W; Cheng N; Zhao Z; Zheng B; Yang Z; Xu Y; Shao Y; Song Y; Lu N; Xue L
    J Pathol; 2022 Dec; 258(4):395-407. PubMed ID: 36098222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing.
    Xue L; Li W; Fan X; Zhao Z; Zhou W; Feng Z; Liu L; Lin H; Li L; Xue X; Huang X; Huang P; Guo J; Du P; Lu N; Li L; Zhan Q; Song Y
    Theranostics; 2020; 10(23):10606-10618. PubMed ID: 32929369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
    Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
    J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases.
    Yuan W; Liu Z; Wang Y; Liu M; Pan Y; Lei W; Yang H; Xu R; Zhang L; Cai H; Li J; Ke Y
    Carcinogenesis; 2019 Dec; 40(12):1445-1451. PubMed ID: 31570939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-genomic analysis reveals eosinophilic feature and favorable prognosis of female non-smoking esophageal squamous cell carcinomas.
    Okawa Y; Sasagawa S; Kato H; Johnson TA; Nagaoka K; Kobayashi Y; Hayashi A; Shibayama T; Maejima K; Tanaka H; Miyano S; Shibahara J; Nishizuka S; Hirano S; Seto Y; Iwaya T; Kakimi K; Yasuda T; Nakagawa H
    Cancer Lett; 2024 Jan; 581():216499. PubMed ID: 38013050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiregion sequencing and subclonal analysis reveal intratumoral heterogeneity in esophageal squamous cell carcinoma.
    Gao D; Zhang Z; Yang Q; Li B
    J Cancer Res Ther; 2021 Jul; 17(3):756-763. PubMed ID: 34269310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis.
    Sano M; Aoyagi K; Takahashi H; Kawamura T; Mabuchi T; Igaki H; Tachimori Y; Kato H; Ochiai A; Honda H; Nimura Y; Nagino M; Yoshida T; Sasaki H
    Int J Oncol; 2010 Feb; 36(2):321-30. PubMed ID: 20043065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis.
    Sunpaweravong S; Bunbanjerdsuk S; Pongrujikorn T; Naktang C; Sunpaweravong P; Nitiruangjaras A; Dechaphankul T; Jinawath N
    BMC Cancer; 2019 Dec; 19(1):1174. PubMed ID: 31795956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment.
    Zhang W; Hong R; Li L; Wang Y; Du P; Ou Y; Zhao Z; Liu X; Xiao W; Dong D; Wu Q; Chen J; Song Y; Zhan Q
    Mol Cancer; 2018 Aug; 17(1):125. PubMed ID: 30131072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma.
    Huang H; Li N; Liang Y; Li R; Tong X; Xiao J; Tang H; Jiang D; Xie K; Fang C; Chen S; Li G; Wang B; Wang J; Luo H; Guo L; Ma H; Jiang W; Feng Y
    Clin Transl Med; 2023 Nov; 13(11):e1493. PubMed ID: 38009315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
    Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death-1 ligands and tumor infiltrating T lymphocytes in primary and lymph node metastasis of esophageal cancer patients.
    Konno-Kumagai T; Fujishima F; Nakamura Y; Nakano T; Nagai T; Kamei T; Sasano H
    Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30085020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCC.
    Deng T; Wang H; Yang C; Zuo M; Ji Z; Bai M; Ning T; Liu R; Wang J; Ge S; Zhang L; Ba Y; Zhang H
    Front Immunol; 2022; 13():1004345. PubMed ID: 36466860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
    Lee HK; Kwon MJ; Ra YJ; Lee HS; Kim HS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Min KW; Kang SY
    Diagn Pathol; 2020 Oct; 15(1):126. PubMed ID: 33054840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.